Loss of HVEM usually drives the development of GCL in vivo and induces a tumor-supportive microenvironment, resulting from the disruption of the interactions between HVEM and BTLA (B and T lymphocyte attenuator) receptors [99, 100]. Here, TNFRSF14 is linked to Berardinelli-Seip congenital lipodystrophy.